VF
AZN icon

Virtu Financial’s AstraZeneca AZN Stock Holding History

Virtu Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,359
Closed -$208K – 1663
2025
Q3 		$208K Buy
+1,359
New +$206K 0.01% 904
2025
Q2 		– Sell
-2,956
Closed -$434K – 1451
2025
Q1 		$434K Sell
2,956
-2,108
-42% -$305K 0.02% 537
2024
Q4 		$663K Sell
5,064
-25,885
-84% -$3.62M 0.04% 419
2024
Q3 		$4.82M Buy
+30,949
New +$5M 0.27% 48
2024
Q1 		– Sell
-2,046
Closed -$276K – 1409
2023
Q4 		$276K Buy
+2,046
New +$266K 0.02% 636
2023
Q3 		– Sell
-1,789
Closed -$256K – 1298
2023
Q2 		$256K Buy
+1,789
New +$263K 0.02% 686
2022
Q4 		– Sell
-18,905
Closed -$2.07M – 1597
2022
Q3 		$2.07M Buy
+18,905
New +$2.4M 0.19% 87
2022
Q2 		– Sell
-3,765
Closed -$499K – 1576
2022
Q1 		$499K Buy
+3,765
New +$452K 0.04% 392
2020
Q4 		– Sell
-2,245
Closed -$246K – 1430
2020
Q3 		$246K Sell
2,245
-2,135
-49% -$237K 0.04% 515
2020
Q2 		$463K Buy
+4,380
New +$452K 0.05% 395
2019
Q4 		$777K Buy
+7,792
New +$734K 0.08% 291
2019
Q3 		– Sell
-2,448
Closed -$202K – 1419
2019
Q2 		$202K Buy
+2,448
New +$192K 0.01% 1017
2018
Q4 		– Sell
-3,011
Closed -$238K – 1548
2018
Q3 		$238K Sell
3,011
-12,530
-81% -$948K 0.01% 982
2018
Q2 		$1.09M Buy
+15,541
New +$1.12M 0.07% 350
2018
Q1 		– Sell
-3,542
Closed -$246K – 1943
2017
Q4 		$246K Buy
+3,542
New +$239K 0.01% 1451
2017
Q2 		– Sell
-3,890
Closed -$242K – 385
2017
Q1 		$242K Buy
+3,890
New +$226K 0.03% 336

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial's AZN Position: Q4 2025 in Review

Virtu Financial sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 1,359 shares — an estimated $208K sold.

Virtu Financial first reported a position in AZN in Q1 2017 and held it in 16 quarters. The position peaked at $4.82M in Q3 2024. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Virtu Financial reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 1,359 AstraZeneca shares in Q4 2025, an estimated $208K.
  • Virtu Financial first reported a position in AstraZeneca in Q1 2017 and held it in 16 quarters.
  • Virtu Financial's AstraZeneca position peaked at $4.82M in Q3 2024.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.